BC
EXAS

Barrett & Company’s Exact Sciences EXAS Stock Holding History

Barrett & Company’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-32
Closed -$2.21K – 607
2024
Q1 		$2.21K Hold
32
– – ﹤0.01% 541
2023
Q4 		$2.37K Hold
32
– – ﹤0.01% 525
2023
Q3 		$2.18K Hold
32
– – ﹤0.01% 542
2023
Q2 		$3K Hold
32
– – ﹤0.01% 504
2023
Q1 		$2.17K Hold
32
– – ﹤0.01% 511
2022
Q4 		$1.58K Hold
32
– – ﹤0.01% 529
2022
Q3 		$1.58K Buy
+32
New +$1.32K ﹤0.01% 529

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Barrett & Company's EXAS Position: Q2 2024 in Review

Barrett & Company sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 32 shares — an estimated $2.21K sold.

Barrett & Company first reported a position in EXAS in Q3 2022 and held it in 7 quarters. The position peaked at $3K in Q2 2023. 543 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • Barrett & Company reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • Barrett & Company sold 32 Exact Sciences shares in Q2 2024, an estimated $2.21K.
  • Barrett & Company first reported a position in Exact Sciences in Q3 2022 and held it in 7 quarters.
  • Barrett & Company's Exact Sciences position peaked at $3K in Q2 2023.
  • 543 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Barrett & Company's 13F filing for Q2 2024, filed 25 Jul 2024.